QUESTION: What is the target of Inebilizumab?

IDEAL_ANSWER:
- Inebilizumab is an anti-CD19 antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells, is currently being evaluated in multiple sclerosis and neuromyelitis optica.

EXACT_ANSWER:
- CD19